Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Share this article:
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Sponsor and Collaborators
Samsung Medical Center

Contact
Kyu-Sung Lee, PhD
82-2-3410-3554
ksleedr@skku.edu

Principal Investigator
Kyu-Sung Lee, PhD
Samsung Medical Center

ClinicalTrials.gov Identifier
NCT00922506
Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Overactive Bladder Clinical Trials

Sign Up for Free e-newsletters

More in Overactive Bladder Clinical Trials

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the ...

A look at the following clinical trial: A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder.

Bladder Thermal Distention for Patients With Refractory Overactive Bladder (OAB)

A look at the following clinical trial: Bladder Thermal Distention for Patients With Refractory Overactive Bladder (OAB).

Peripheral Electrical Stimulation for the Treatment of Overactive Bladder (PESTOB)

A look at the following clinical trial: Peripheral Electrical Stimulation for the Treatment of Overactive Bladder (PESTOB).